| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.656 | 5.746 | 35.892 | 59.003 | 59.604 | 106.341 | 135.494 | 153.319 | 103.130 |
| Total Income - EUR | - | 5.658 | 5.746 | 35.892 | 58.985 | 60.347 | 106.026 | 135.390 | 153.320 | 398.244 |
| Total Expenses - EUR | - | 4.122 | 4.014 | 33.718 | 44.695 | 39.275 | 104.940 | 112.504 | 95.741 | 287.993 |
| Gross Profit/Loss - EUR | - | 1.536 | 1.732 | 2.174 | 14.290 | 21.072 | 1.086 | 22.886 | 57.578 | 110.251 |
| Net Profit/Loss - EUR | - | 1.366 | 1.560 | 1.815 | 13.700 | 20.737 | 152 | 21.670 | 56.265 | 98.878 |
| Employees | - | 0 | 0 | 3 | 3 | 3 | 4 | 7 | 5 | 2 |
Check the financial reports for the company - Cajumed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 441 | 160 | 3.670 | 3.106 | 2.564 | 240.337 | 237.099 | 231.344 | 32.084 |
| Current Assets | - | 1.470 | 2.973 | 8.680 | 18.708 | 23.047 | 23.453 | 12.108 | 27.246 | 123.577 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 1.318 | 1.453 | 1.590 | 1.582 |
| Receivables | - | 950 | 2.094 | 4.511 | 8.788 | 5.980 | 13.415 | 10.087 | 24.140 | 709 |
| Cash | - | 520 | 879 | 4.168 | 9.920 | 17.067 | 8.719 | 568 | 1.516 | 121.287 |
| Shareholders Funds | - | 1.411 | 2.947 | 4.708 | 13.742 | 20.778 | 10.361 | 32.064 | 88.232 | 98.926 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 500 | 186 | 7.641 | 8.072 | 4.833 | 253.428 | 217.143 | 170.358 | 56.735 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cajumed S.r.l.